A cohort of 22 patients at CP-CML and 14 patients at BC-CML was analyzed for CD25 expression using qRT-PCR as compared to ABL control (Table 3). The gene discussed is IL2RA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.